Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: Pharmacoepidemiol Drug Saf. 2011 Jul 28;20(9):903–913. doi: 10.1002/pds.2181

FIGURE 1.

FIGURE 1

Adjusted* hazard ratios for SD/VA associated with antidepressant exposure, using paroxetine as the reference

*adjusted for age, sex, race, state, nursing home residence, an ever-past bipolar disorder diagnosis, and an ever-past angiotensin-converting enzyme inhibitor or angiotensin-II receptor blocker prescription